Drug-target-ADR Network and Possible Implications of Structural Variants in Adverse Events - Unité de Biologie Fonctionnelle et Adaptative Accéder directement au contenu
Article Dans Une Revue Molecular Informatics Année : 2020

Drug-target-ADR Network and Possible Implications of Structural Variants in Adverse Events

Résumé

Adverse drug reactions (ADRs) are of major concern in drug safety. However, due to the biological complexity of human systems, understanding the underlying mechanisms involved in development of ADRs remains a challenging task. Here, we applied network sciences to analyze a tripartite network between 1000 drugs, 1407 targets, and 6164 ADRs. It allowed us to suggest drug targets susceptible to be associated to ADRs and organs, based on the system organ class (SOC). Furthermore, a score was developed to determine the contribution of a set of proteins to ADRs. Finally, we identified proteins that might increase the susceptibility of genes to ADRs, on the basis of knowledge about genomic structural variation in genes encoding proteins targeted by drugs. Such analysis should pave the way to individualize drug therapy and precision medicine.
Fichier principal
Vignette du fichier
MINF-39-2000116.pdf (3.51 Mo) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)

Dates et versions

hal-03300415 , version 1 (15-11-2022)

Identifiants

Citer

Bryan Dafniet, Natacha Cerisier, Karine Audouze, Olivier Taboureau. Drug-target-ADR Network and Possible Implications of Structural Variants in Adverse Events. Molecular Informatics, 2020, 39 (12), ⟨10.1002/minf.202000116⟩. ⟨hal-03300415⟩
34 Consultations
13 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More